et al., National Science Review, nwaa113, doi:10.1093/nsr/nwaa113 (Peer Reviewed)
197 CQ patients, 176 control. Mean time to undetectable viral RNA and duration of fever significantly reduced. No serious adverse events.
Huang et al., 5/28/2020, prospective, China, Asia, peer-reviewed, 36 authors.
time to viral-, 67.0% lower, relative time 0.33, p < 0.001, treatment 197, control 176.
time to viral-, 59.1% lower, relative time 0.41, p < 0.001, treatment 32, control 37, early treatment.